| Application no. and date | 09786960.6 (espacenet) (Federated) (European Patent Register), 20090817 | | Patent/reg. no. and date | DK/EP 2334687, 20120104 | | Publication date | 20110622 | | Priority no. and date | US 92470 P, 20080828, US 227212 P, 20090721 | | EP pub. no. and date |
EP 2334687 20110622 | | Effective date | | | Applicant/owner | Pfizer Inc., 66 Hudson Boulevard East
New York, NY 10001-2192, US | | Applicant ref. no. | P81200203DK00E | | Inventor | MASCITTI, Vincent, Pfizer Global Research and Development
Eastern Point Road
Groton, Connecticut 06340, US,
COLLMAN, Benjamin, Micah, 3011 Washington Ave
Willmett, IL, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/357 (2006.01) , A61P 3/10 (2006.01) , C07D 493/10 (2006.01) , C07H 15/18 (2006.01) | | Title | Dioxa-bicyclo[3.2.1.]octan-2,3,4-triol-derivater | | Int. application no. | IB2009053626 | | Int. publication no. | WO2010023594 | | Related patent (certificate) | CA 2018 00025 | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
